Search

Your search keyword '"Verastegui M"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Verastegui M" Remove constraint Author: "Verastegui M"
137 results on '"Verastegui M"'

Search Results

51. Small molecule biomarkers predictive of Chagas disease progression.

52. Identification and evaluation in-vitro of conserved peptides with high affinity to MHC-I as potential protective epitopes for Newcastle disease virus vaccines.

53. Does food biodiversity protect against malnutrition and favour the resilience to climate change-related events in Amazon Indigenous communities? A protocol for a mixed methods study.

54. Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy.

55. Building Public Health Capacity through a Sustainable South-South-North Training Program.

56. Development and Validation of a Copro-Enzyme-Linked Immunosorbent Assay Sandwich for Detection of Echinococcus granulosus -Soluble Membrane Antigens in Dogs.

57. Improved DNA extraction technique from clot for the diagnosis of Chagas disease.

58. Carotid Taenia solium Oncosphere Infection: A Novel Porcine Neurocysticercosis Model.

59. Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting.

60. Etiological Role and Repeated Infections of Sapovirus among Children Aged Less than 2 Years in a Cohort Study in a Peri-urban Community of Peru.

61. Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

62. In Vitro Study of Taenia solium Postoncospheral Form.

63. Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in Bolivia.

66. Prevalence and Transmission of Trypanosoma cruzi in People of Rural Communities of the High Jungle of Northern Peru.

67. Trypanosoma cruzi-infected pregnant women without vector exposure have higher parasitemia levels: implications for congenital transmission risk.

68. Neurocysticercosis: A natural human model of epileptogenesis.

69. Field evaluation of the InBios Chagas detect plus rapid test in serum and whole-blood specimens in Bolivia.

70. Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.

71. Characterization of the carbohydrate components of Taenia solium oncosphere proteins and their role in the antigenicity.

72. Standardization of a fluorescent-based quantitative adhesion assay to study attachment of Taenia solium oncosphere to epithelial cells in vitro.

73. Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

74. Anti-triatomine saliva immunoassays for the evaluation of impregnated netting trials against Chagas disease transmission.

75. Chagas cardiomyopathy in the context of the chronic disease transition.

76. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.

77. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection.

78. Polymerase chain reaction for chronic Trypanosoma cruzi infection yields higher sensitivity in blood clot than buffy coat or whole blood specimens.

79. Diagnosis of cystic echinococcosis, central Peruvian Highlands.

80. Characterization of a novel Taenia solium oncosphere antigen.

81. Taenia solium oncosphere adhesion to intestinal epithelial and Chinese hamster ovary cells in vitro.

82. Comparison of the peptidase activity in the oncosphere excretory/secretory products of Taenia solium and Taenia saginata.

83. Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway.

84. Can Taenia solium latent post-oncospheral stages be found in muscle tissue of cysticercosis-infected pigs (Sus scrofa)?

85. Vaccination of pigs to control human neurocysticercosis.

86. Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay.

87. Report of an unusual case of persistent bacteremia by Bartonella bacilliformis in a splenectomized patient.

88. Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis.

89. Evaluation of the enzyme-linked immunoelectrotransfer blot (EITB) for ovine hydatidosis relative to age and cyst characteristics in naturally infected sheep.

90. Hyperendemic human and porcine Taenia solium infection in Perú.

91. Taenia solium oncosphere antigens induce immunity in pigs against experimental cysticercosis.

92. Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children.

93. Protection of pigs with cysticercosis from further infections after treatment with oxfendazole.

94. Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

95. Field diagnosis of Echinococcus granulosus infection among intermediate and definitive hosts in an endemic focus of human cystic echinococcosis.

96. Human hydatidosis in the central Andes of Peru: evolution of the disease over 3 years.

97. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.

98. Immunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru.

99. Rates of tetanus protection and transplacental tetanus antibody transfer in pregnant women from different socioeconomic groups in Peru.

100. Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children.

Catalog

Books, media, physical & digital resources